Noul Co., Ltd.
Founded in 2015 and listed on KOSDAQ in 2022, Noul develops the on-device AI diagnostic platform miLab™ for blood and cancer testing.
Price
Change
Market cap
Products & technology
- miLab™ Malaria DiagnosticsMalaria diagnosis
- miLab™ Peripheral Blood Smear TestPeripheral blood smear testing
- miLab™ Cervical Cytology AnalysisCervical cytology analysis (cancer diagnosis)
Regulatory approvals
data.go.kr17 Korean MFDS device approvals · 2019–2024
- MFDSHematology analyzer, cell-quantifying2024-10-25Product approval · Class 1체외 제신 24-1310 호
- MFDSImage processing software for pathological cells or tissue2023-12-04Product approval · Class 1체외 제신 23-1722 호
- MFDSComputer aided diagnosis software for pathological cells or tissue2023-09-22Product approval · Class 3체외 제허 23-940 호
- MFDSComputer aided diagnosis software for pathological cells or tissue2023-09-01Product approval · Class 3체외 제허 23-887 호
- MFDSCell/histopathologic image processor2023-08-01Product approval · Class 1체외 제신 23-1182 호
- MFDSHistological staining reagent Ⅰ2022-11-09Product approval · Class 1체외 제신 22-1564 호
- MFDSHistological staining reagent Ⅰ2022-11-09Product approval · Class 1체외 제신 22-1563 호
- MFDSHistological staining reagent Ⅰ2022-02-08Product approval · Class 1체외 제신 22-162 호
- MFDSIVD reagents for hematological stains2021-04-26Product approval · Class 1체외 제신 21-564 호
- MFDSHistological staining reagent ⅠRevoked2021-04-09Product approval · Class 1체외 제신 21-484 호
- MFDSIVD reagents for hematological stains2021-04-09Product approval · Class 1체외 제신 21-483 호
- MFDSHistological staining reagent ⅠRevoked2021-04-08Product approval · Class 1체외 제신 21-480 호
Show 5 more
- MFDSHistological staining reagent ⅠRevoked2021-04-08Product approval · Class 1체외 제신 21-479 호
- MFDSHistological staining reagent ⅠRevoked2021-02-01Product approval · Class 1체외 제신 21-127 호
- MFDSCell/histopathology diagnostic analyzerRevoked2020-09-02Product approval · Class 2체외 제허 20-774 호
- MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), immunological methodRevoked2020-03-16Product approval · Class 3체외 제허 20-188 호
- MFDSHematology analyzer, cell-quantifying2019-10-08Product approval · Class 1체외 제신 19-1320 호
Companies approved for the same productsMedical Devices
Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.
Founded in 1987 and listed on KOSDAQ in 2000, NanoenTek develops Lab-On-a-Chip in-vitro diagnostic devices and life science instruments.
KOSDAQ-listed point-of-care immunodiagnostics company supplying diagnostic cartridges and the ichroma/AFIAS instrument series.
GC Medical Science Corporation, KOSDAQ-listed since 2014, operates diagnostic reagent, blood glucose, and hemodialysis solution businesses.
EDGC, a Korea-US joint venture of Eone Medical Foundation and Diagnomics, offers the NIPT service NICE and liquid biopsy OncoCatch.
KOSDAQ-listed biotech company developing molecular diagnostics with proprietary C-Tag technology and the NeoPlex product line.
KOSDAQ-listed aesthetics and CMO company behind the Elravie/Revolax hyaluronic-acid fillers and Leedstox botulinum toxin.
IVIM Technology provides all-in-one intravital microscopes and CRO imaging-analysis services for live-animal organ and tissue research.
KOSDAQ-listed bioprocess and biomedical company supplying the CELBIC single-use cell culture system and the DxBIC automated analysis system.
Founded 1996, listed on KOSDAQ in 2024, OSANG HEALTHCARE develops and sells biochemistry, immunodiagnostic, and molecular IVD products.
KOSDAQ-listed IVD company using SG Cap™ multiplex diagnostic technology for infectious disease, cancer, and companion animal testing.
KOSDAQ-listed in-vitro diagnostics company developing the LabChip-based VERI-Q molecular diagnostic device series.
Vieworks, founded in 1999 and KOSDAQ-listed in 2009, develops X-ray detectors and industrial camera imaging solutions.
Sources and updates
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- AI visibility
- Measured 2026-08-13
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition